Impact of United States Food and Drug Administration Position Statements on Complication Rates Within 30 Days After

Arshia Aalami Harandi1, Natalie Braun2, Jason Kim1

  • 1Department of Urology, Stony Brook University Medical Center, Stony Brook, New York.

Urology Practice
|June 27, 2025
PubMed
Abstract

Insights

The US Food and Drug Administration

Area of Science:

  • Urology
  • Gynecology
  • Surgical Quality Improvement

Background:

  • US Food and Drug Administration (FDA) issued notices on synthetic mesh for stress urinary incontinence (SUI) surgery.
  • A 2011 FDA report detailed adverse events like erosion, infection, and pain from SUI mesh procedures.

Purpose of the Study:

  • To investigate the impact of FDA notices on SUI sling placement and complication rates.
  • To analyze changes in surgical practice and patient outcomes following FDA communications.

Main Methods:

  • Retrospective analysis of the National Surgical Quality Improvement Program (NSQIP) database (2008-2020).
  • Included 41,856 SUI sling procedures (CPT code 57288), excluding specific patient and surgical criteria.

Main Results:

  • A significant decline in SUI sling complications was observed post-2011 FDA statement.
  • An increase in fascial slings and a decrease in overall complications (18%) occurred.
  • Urologist-performed procedures had 41% fewer complications; fascial slings showed 4-fold increased complication odds.

Conclusions:

  • FDA monitoring and communication influence surgical practices and outcomes for synthetic implants.
  • Further research is needed on the frequency and impact of FDA communication for implantable synthetics.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...